U.S. Supreme Court to Review FDA's Rejection of Flavored Vape PMTAs

Nov.26.2024
U.S. Supreme Court to Review FDA's Rejection of Flavored Vape PMTAs
The U.S. Supreme Court will hear a case regarding FDA's rejection of PMTAs for flavored vape products from two companies. Lower courts previously ruled that FDA did not follow proper legal procedures when rejecting the applications. The Supreme Court plans to hear the case in its upcoming term.

According to a report by Tobacco Reporter on November 25th, the US Supreme Court will next week hear arguments from the Food and Drug Administration (FDA) regarding the rejection of pre-market tobacco product applications (PMTA) from two companies. These companies wish to sell flavored vape products that are considered to pose health risks to young consumers.

 

Previously, a lower court ruled that FDA did not follow proper legal procedures under federal law when rejecting the applications of these two companies to market their nicotine products. The Supreme Court has decided to hear FDA's appeal and plans to hear the case in the next session, which begins in October.

 

Two e-cigarette liquid manufacturers, Triton Distribution and Vapetasia, submitted pre-market tobacco product applications in 2020, which included flavors such as sour grape, pink lemonade, and caramel pudding. The products had names like "Jimmy The Juice Man Strawberry Astronaut" and "Suicide Bunny Bunny Season." FDA rejected the applications from these two companies and over a million other products.

 

In 2021, Triton and Vapetasia applied for a review of the FDA's rejection decision with the United States Fifth Circuit Court of Appeals in New Orleans. In January of this year, the Fifth Circuit Court of Appeals ruled that FDA was too arbitrary in its denial of the application and did not consider the companies' plans to prevent minors from accessing and using their products.

 

Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
The U.S. FDA has added six ON!® PLUS nicotine pouch products to its list of Marketing Granted Order (MGO) authorizations. Based on 2Firsts’ review, the approved products feature a highly standardized configuration in terms of format, nicotine strength, and flavour portfolio, primarily focusing on 6 mg and 9 mg strengths and traditional variants such as mint, wintergreen, and tobacco—reflecting a clear compliance-oriented approach.
Dec.22 by 2FIRSTS.ai
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
E-cigarette brand IVG has recently rolled out the IVG Pro 2 across several UK online retailers. The device is compatible with IVG Pro pods and comes in 33 flavours with nicotine strengths of 0mg, 10mg and 20mg. Channel listings show a 2ml prefilled pod paired with a 10ml refill container, with pricing around £9.99.
Feb.02 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11
Haypp Report Shows Mint Tops Nicotine Pouch Flavours, Berry Leads Vapes in the UK
Haypp Report Shows Mint Tops Nicotine Pouch Flavours, Berry Leads Vapes in the UK
Online retailer Haypp has released its 2025 Haypp Wrapped report, detailing flavour and brand preferences among UK nicotine pouch and vape users. The report found that mint flavours dominated the nicotine pouch market, while berry flavours were most popular among vape users. Velo and Nordic Spirit led the nicotine pouch category, while Elf Bar and Vuse topped the vape brand rankings.
Dec.24 by 2FIRSTS.ai
Heated tobacco brand DIITO launches in Mongolia
Heated tobacco brand DIITO launches in Mongolia
A new heat-not-burn (HNB) brand, DIITO, has commenced promotional activities in the Mongolian market. The device features an integrated display panel and supports dual heating modes, "RELAX" and "RUSH." Investigations reveal that DIITO’s local promotion closely overlaps with RELX’s official distribution channels. Furthermore, the DIITO trademark is held by the UK-based REAZEN TECH LIMITED, a company that also manages the e-cigarette brand FASTA.
Jan.16 by 2FIRSTS.ai